• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Prescription for COVID-19 by non-medical professionals during the pandemic in Colombia: a cross-sectional study.哥伦比亚疫情期间非医学专业人员开具的新冠处方:一项横断面研究
Ther Adv Drug Saf. 2022 May 24;13:20420986221101964. doi: 10.1177/20420986221101964. eCollection 2022.
2
Drug safety of frequently used drugs and substances for self-medication in COVID-19.新型冠状病毒肺炎(COVID-19)中常用的自我药疗药物和物质的药物安全性。
Ther Adv Drug Saf. 2022 Apr 21;13:20420986221094141. doi: 10.1177/20420986221094141. eCollection 2022.
3
Demand of COVID-19 medicines without prescription among community pharmacies in Jodhpur, India: Findings and implications.印度焦特布尔社区药房中无需处方的新冠病毒药品需求:研究结果与启示
J Family Med Prim Care. 2022 Feb;11(2):503-511. doi: 10.4103/jfmpc.jfmpc_1250_21. Epub 2022 Feb 16.
4
Evaluation of the effects of a drug with fiscalized substance dispensation, health education, and pharmacovigilance continuing education program in Colombia drugstores and drugstores/pharmacies: study protocol of a multicenter, cluster-randomized controlled trial.评价具有财政化物质配给、健康教育和药物警戒继续教育项目的药物对哥伦比亚药店和药店/药房的影响:一项多中心、集群随机对照试验的研究方案。
Trials. 2020 Jun 19;21(1):545. doi: 10.1186/s13063-020-04481-1.
5
Primary health care policy and vision for community pharmacy and pharmacists in Colombia.哥伦比亚社区药房和药剂师的初级卫生保健政策与愿景。
Pharm Pract (Granada). 2020 Oct-Dec;18(4):2159. doi: 10.18549/PharmPract.2020.4.2159. Epub 2020 Nov 23.
6
Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.用于评估非住院轻中度 COVID-19 患者肠道微生物组调节的自然史和影响的虚拟化临床研究:一项随机、开放标签、前瞻性研究,平行组研究评估 KB109 对肠道微生物组结构和功能的生理影响:一项随机对照研究方案的结构化总结。
Trials. 2021 Apr 2;22(1):245. doi: 10.1186/s13063-021-05157-0.
7
Sales of "COVID kit" drugs and adverse drug reactions reported by the Brazilian Health Regulatory Agency.巴西卫生监管机构报告的“COVID 试剂盒”药物销售和药物不良反应。
Cad Saude Publica. 2022 Jul 25;38(7):e00001022. doi: 10.1590/0102-311XEN001022. eCollection 2022.
8
Pharmaceutical counseling: Between evidence-based medicine and profits.药学咨询:在循证医学与利润之间
Int J Risk Saf Med. 2015;27 Suppl 1:S87-8. doi: 10.3233/JRS-150701.
9
Assessing pharmaceutical consultations: Comparing pharmacy-recommended medications for minor ailments and regulatory compliance in a Latin American healthcare network.评估药学咨询:比较拉丁美洲医疗网络中针对小病的药房推荐药物及法规遵从情况。
Explor Res Clin Soc Pharm. 2023 Jul 6;11:100300. doi: 10.1016/j.rcsop.2023.100300. eCollection 2023 Sep.
10
A survey on self-medication for the prevention or treatment of COVID-19 and distrust in healthcare of veterans in a primary care setting in the United States.美国基层医疗环境中退伍军人预防或治疗新冠病毒病的自我药疗及对医疗保健不信任情况的调查
Ther Adv Drug Saf. 2022 Dec 15;13:20420986221143265. doi: 10.1177/20420986221143265. eCollection 2022.

引用本文的文献

1
Patterns of Opioid and Non-Opioid Analgesic Consumption in Patients with Post-COVID-19 Conditions.新冠后综合征患者阿片类和非阿片类镇痛药的使用模式
J Clin Med. 2023 Oct 18;12(20):6586. doi: 10.3390/jcm12206586.
2
Enhancing self-medication practices in the era of infodemic: the role of pharmacovigilance.在信息疫情时代加强自我药疗行为:药物警戒的作用
Ther Adv Drug Saf. 2023 Aug 23;14:20420986231194754. doi: 10.1177/20420986231194754. eCollection 2023.
3
A Formative Assessment of Antibiotic Dispensing/Prescribing Practices and Knowledge and Perceptions of Antimicrobial Resistance (AMR) among Healthcare Workers in Lahore Pakistan.巴基斯坦拉合尔医护人员抗生素配药/开处方行为以及对抗菌素耐药性(AMR)的知识和认知的形成性评估
Antibiotics (Basel). 2022 Oct 16;11(10):1418. doi: 10.3390/antibiotics11101418.

本文引用的文献

1
The effect of supplementation with vitamins A, B, C, D, and E on disease severity and inflammatory responses in patients with COVID-19: a randomized clinical trial.补充维生素 A、B、C、D 和 E 对 COVID-19 患者疾病严重程度和炎症反应的影响:一项随机临床试验。
Trials. 2021 Nov 14;22(1):802. doi: 10.1186/s13063-021-05795-4.
2
Drug Interactions for Patients with Respiratory Diseases Receiving COVID-19 Emerged Treatments.接受新冠病毒治疗的呼吸疾病患者的药物相互作用。
Int J Environ Res Public Health. 2021 Nov 8;18(21):11711. doi: 10.3390/ijerph182111711.
3
Self-medication practices to prevent or manage COVID-19: A systematic review.自我用药预防或管理 COVID-19 的实践:系统评价。
PLoS One. 2021 Nov 2;16(11):e0259317. doi: 10.1371/journal.pone.0259317. eCollection 2021.
4
Medicines for the new coronavirus in the view of Classical Systemic Homeopathy.古典全身顺势疗法视角下的新型冠状病毒治疗药物
Complement Ther Clin Pract. 2021 Nov;45:101482. doi: 10.1016/j.ctcp.2021.101482. Epub 2021 Sep 11.
5
Hemorrhagic and thrombotic manifestations in the central nervous system in COVID-19: A large observational study in the Brazilian Amazon with a complete autopsy series.COVID-19 患者中枢神经系统出血和血栓形成表现:巴西亚马逊地区一项包含完整尸检系列的大型观察性研究
PLoS One. 2021 Sep 10;16(9):e0255950. doi: 10.1371/journal.pone.0255950. eCollection 2021.
6
The long-term sequelae of COVID-19: an international consensus on research priorities for patients with pre-existing and new-onset airways disease.新型冠状病毒肺炎的长期后遗症:针对既往存在和新发气道疾病患者的研究重点国际共识
Lancet Respir Med. 2021 Dec;9(12):1467-1478. doi: 10.1016/S2213-2600(21)00286-1. Epub 2021 Aug 17.
7
Self-prescribed Ivermectin use is associated with a lower rate of seroconversion in health care workers diagnosed with COVID, in a dose-dependent response.自我处方伊维菌素的使用与 COVID 确诊医护人员的血清转化率降低有关,且呈剂量依赖性反应。
Braz J Infect Dis. 2021 Jul-Aug;25(4):101603. doi: 10.1016/j.bjid.2021.101603. Epub 2021 Aug 12.
8
Genetic and Molecular Aspects of Drug-Induced QT Interval Prolongation.药物引起 QT 间期延长的遗传和分子方面。
Int J Mol Sci. 2021 Jul 28;22(15):8090. doi: 10.3390/ijms22158090.
9
Ivermectin for preventing and treating COVID-19.伊维菌素预防和治疗 COVID-19。
Cochrane Database Syst Rev. 2021 Jul 28;7(7):CD015017. doi: 10.1002/14651858.CD015017.pub2.
10
Therapeutic Effectiveness and Safety of Repurposing Drugs for the Treatment of COVID-19: Position Standing in 2021.药物重新利用治疗新冠肺炎的疗效与安全性:2021年立场声明
Front Pharmacol. 2021 Jun 14;12:659577. doi: 10.3389/fphar.2021.659577. eCollection 2021.

哥伦比亚疫情期间非医学专业人员开具的新冠处方:一项横断面研究

Prescription for COVID-19 by non-medical professionals during the pandemic in Colombia: a cross-sectional study.

作者信息

Nino-Orrego Maria Jose, Baracaldo-Santamaría Daniela, Patricia Ortiz Claudia, Zuluaga Heyde Patricia, Cruz-Becerra Sthefany Alejandra, Soler Franklin, Pérez-Acosta Andrés M, Delgado Daniel Ricardo, Calderon-Ospina Carlos-Alberto

机构信息

Center for Research in Genetics and Genomics (CIGGUR), School of Medicine and Health Sciences, Universidad del Rosario, Bogotá, Colombia.

Pharmacology Unit, Department of Biomedical Sciences, School of Medicine and Health Sciences, Universidad del Rosario, Bogotá, Colombia.

出版信息

Ther Adv Drug Saf. 2022 May 24;13:20420986221101964. doi: 10.1177/20420986221101964. eCollection 2022.

DOI:10.1177/20420986221101964
PMID:35646306
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9136451/
Abstract

BACKGROUND

The COVID-19 pandemic has led to an increase in the behavior of self-medication (SM). Given the massive release of misleading information during the pandemic, some pharmacies recommend drugs such as ivermectin, azithromycin, and hydroxychloroquine that are not useful for preventing or treating COVID-19 and could expose patients to unnecessary adverse drug reactions (ADRs), drug-drug interactions (DDIs), disease masking, and antibiotic resistance.

RATIONALE

SM with drugs advertised for COVID-19 can have consequences, and people should be aware of approved uses, potential contraindications, and ADRs. Thus, the aim of this study was to know the drug therapies including natural products and homeopathic drugs offered by Colombian pharmaceutical establishments for the prevention and treatment of COVID-19, as well as the information provided on the safe use of the product.

METHODS

An observational, cross-sectional mystery shopping study was carried out to determine the pharmaceutical alternatives for the management of COVID-19 offered by pharmaceutical establishments (drugstores, pharmacies, homeopathic pharmacies, and nutritional supplements stores) in Colombia, and information related to the safe use of the product. The study included 482 pharmaceutical establishments from 16 Colombian departments. Data collection was done through telephone calls to each of the establishments following an interview protocol pretending to be a patient who presents symptoms related to COVID-19.

RESULTS

About 57.3% (276) of the establishments recommended a product for the treatment of COVID-19 infection, 66.6% (321) asked whether the caller had COVID-19 symptoms and what they are, and 44.2% (213) suggested taking a COVID-19 test. Of 59 drugs suggested by pharmacies, the most recommended were azithromycin, ivermectin, acetaminophen, ibuprofen, and ASA (aspirin). From the establishments that recommended a product, dosage was indicated in 85.5% (236) of the pharmaceutical establishments and 14.5% (40) of the establishments reported the most common adverse effects of this substance. About 9.4% (26) of the establishments reported possible interactions of the recommended drugs and substances with food, beverages, or supplements. Pharmaceutical establishments in Colombia seem to have significantly contributed to self-medication for COVID-19 in Colombia during the pandemic. This behavior is inappropriate, since the mild forms of the disease do not have a specific treatment.

PLAIN LANGUAGE SUMMARY

The COVID-19 pandemic has led to an increase in the behavior of self-medication (SM). Given the massive release of misleading information during the pandemic, some pharmacies recommend drugs such as ivermectin, azithromycin, hydroxychloroquine among others, which are not useful for preventing or treating COVID-19 and could expose patients to unnecessary side effects and interactions with other medications. People should be aware of the approved and non-approved uses, and potential side effects of these drugs. The aim of this study was to know the drugs, including natural products and homeopathic drugs, offered by Colombian pharmaceutical establishments for the prevention and treatment of COVID-19, as well as the information provided on the safe use of the product. The study was done using the mystery shopping method, collecting data through telephone calls to each of the establishments by a trained individual pretending to be a patient with COVID-19 symptoms. The study included 482 pharmaceutical establishments from 16 Colombian departments. Of 59 drugs suggested by pharmacies, the most recommended were azithromycin, ivermectin, acetaminophen, ibuprofen, and aspirin. The recommended dose was indicated in 85.5% (236) of the pharmaceutical establishments, and 14.5% (40) of them reported the most common adverse effects of the recommended product. About 9.4% (26) of the establishments reported possible interactions of the recommended drugs and substances with food, beverages, or supplements. The majority of the pharmaceutical establishments included in the study promoted inadequate self-medication for COVID-19 in Colombia during the pandemic.

摘要

背景

新冠疫情导致自我药疗行为增加。鉴于疫情期间大量误导性信息的传播,一些药店推荐使用伊维菌素、阿奇霉素和羟氯喹等对预防或治疗新冠病毒病并无作用的药物,这些药物可能会使患者面临不必要的药物不良反应、药物相互作用、疾病掩盖及抗生素耐药性问题。

理论依据

使用宣传用于新冠病毒病的药物进行自我药疗可能会产生后果,人们应了解其获批用途、潜在禁忌和药物不良反应。因此,本研究的目的是了解哥伦比亚制药机构提供的用于预防和治疗新冠病毒病的药物疗法,包括天然产品和顺势疗法药物,以及所提供的关于产品安全使用的信息。

方法

开展了一项观察性横断面神秘顾客研究,以确定哥伦比亚的制药机构(药店、药房、顺势疗法药房和营养补充剂商店)提供的用于管理新冠病毒病的药物替代品,以及与产品安全使用相关的信息。该研究涵盖了来自哥伦比亚16个部门的482家制药机构。数据收集是通过按照访谈协议致电每家机构来完成的,假装是一名出现与新冠病毒病相关症状的患者。

结果

约57.3%(276家)机构推荐了用于治疗新冠病毒感染的产品,66.6%(321家)询问来电者是否有新冠病毒病症状以及症状是什么,44.2%(213家)建议进行新冠病毒检测。在药店推荐的59种药物中,最常被推荐的是阿奇霉素、伊维菌素、对乙酰氨基酚、布洛芬和阿司匹林。在推荐了产品的机构中,85.5%(236家)制药机构指明了剂量,14.5%(40家)机构报告了该物质最常见的不良反应。约9.4%(26家)机构报告了所推荐药物和物质与食物、饮料或补充剂之间可能存在的相互作用。哥伦比亚的制药机构在疫情期间似乎对哥伦比亚的新冠病毒病自我药疗起到了显著的推动作用。这种行为是不恰当的,因为该疾病的轻症形式并无特定治疗方法。

简明语言摘要

新冠疫情导致自我药疗行为增加。鉴于疫情期间大量误导性信息的传播,一些药店推荐伊维菌素、阿奇霉素、羟氯喹等药物,这些药物对预防或治疗新冠病毒病并无作用,可能会使患者面临不必要的副作用以及与其他药物的相互作用。人们应了解这些药物的获批和未获批用途以及潜在副作用。本研究的目的是了解哥伦比亚制药机构提供的用于预防和治疗新冠病毒病的药物,包括天然产品和顺势疗法药物,以及所提供的关于产品安全使用的信息。该研究采用神秘顾客法,由一名经过培训的人员假装是一名有新冠病毒病症状的患者,通过致电每家机构来收集数据。该研究涵盖了来自哥伦比亚16个部门的482家制药机构。在药店推荐的59种药物中,最常被推荐的是阿奇霉素、伊维菌素、对乙酰氨基酚、布洛芬和阿司匹林。85.5%(236家)制药机构指明了推荐剂量,其中14.5%(40家)报告了所推荐产品最常见的不良反应。约9.4%(26家)机构报告了所推荐药物和物质与食物、饮料或补充剂之间可能存在的相互作用。研究中的大多数制药机构在疫情期间推动了哥伦比亚不恰当的新冠病毒病自我药疗行为。